Jaguar Animal Health (NASDAQ:JAGX – Get Free Report) released its earnings results on Monday. The biotechnology company reported ($9.23) earnings per share for the quarter, beating the consensus estimate of ($444.29) by $435.06, FiscalAI reports. The company had revenue of $2.34 million for the quarter, compared to the consensus estimate of $4.85 million.
Jaguar Animal Health Price Performance
Shares of JAGX stock opened at $0.38 on Wednesday. Jaguar Animal Health has a 1-year low of $0.33 and a 1-year high of $981.75. The stock’s 50-day moving average is $3.80 and its 200 day moving average is $97.92. The company has a market cap of $740,805.00, a P/E ratio of -0.00 and a beta of -0.09. The company has a debt-to-equity ratio of 0.35, a current ratio of 0.69 and a quick ratio of 0.40.
Analysts Set New Price Targets
Several brokerages have recently weighed in on JAGX. Weiss Ratings reiterated a “sell (e+)” rating on shares of Jaguar Animal Health in a report on Thursday, October 15th. Wall Street Zen upgraded Jaguar Animal Health to a “sell” rating in a research note on Saturday, October 10th. One research analyst has rated the stock with a Sell rating. Based on data from MarketBeat, the company has an average rating of “Sell”.
Jaguar Animal Health Company Profile
Jaguar Health, Inc., formerly Jaguar Animal Health, develops prescription medicines for gastrointestinal disorders in humans and animals. The company’s research has focused on plant-derived compounds, including crofelemer, which is derived from the Croton lechleri tree. Jaguar’s animal-health product Canalevia-CA1 received FDA conditional approval for the treatment of chemotherapy-induced diarrhea in dogs. The company also develops and commercializes crofelemer-based medicines for human gastrointestinal conditions.
Read More
- Five stocks we like better than Jaguar Animal Health
- AMD Bets $8.2B on Physical AI: Could Robotics Be Its Next Growth Frontier?
- 3 Stocks Flashing Buy Signals With Historical Win Rates Above 85% After the Sell-Off
- Disney Has the Magic Touch: Dividend Growth and Buybacks Could Fuel a Breakout
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
Receive News & Ratings for Jaguar Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.
